Barry Callebaut Gets Cocoa Health Claim
A European health claim supports cocoa flavanols for their contribution to healthy blood flow.
Barry Callebaut (Zurich, Switzerland) has earned a cocoa health claim in Europe for cocoa flavanols and healthy blood flow. The company says its cocoa health claim is the first such claim in the world.
On September 3, the European Commission approved the following health claim for cocoa flavanols: “cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow.”
Because of a proprietary processing method, Barry Callebaut can retain as much as 80% of cocoa’s natural flavanols-beneficial compounds which often degrade during high-heat processing of cocoa and chocolate. The processing method is used in the company’s ACTICOA line of cocoa flavanol ingredients, and it was integral to achieving the European health claim. Cocoa flavanols have shown blood flow support in numerous studies, and with numerous suppliers’ flavanols, but the health claim is restricted to Barry Callebaut ingredients for a period of five years.
The cocoa health claim is available for servings of 200 mg of cocoa flavanols, a dose that is achievable with 2.5 g of ACTICOA powder or 10 g of ACTICOA dark chocolate. For now, the claim is restricted to beverages (made with cocoa powder) and dark chocolate.
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
